Nepal became the third country to approve India's indigenously developed Covid-19 vaccine when the national drug regulatory authority of Nepal granted the emergency use approval to Bharat Biotech's Covaxin.
The Drug Advisory Committee of the Department of Drug Administration conducted a meeting and decided to issue a conditional emergency use authorisation to India's homegrown government-backed vaccine Covaxin, the third Covid-19 vaccine authorised in the country, as reported by the Kathmandu Post .
The latest approval comes as authorities in Nepal said they were suspending their vaccination campaign because of a lack of supply.
Covaxin, which demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials India, was approved for emergency use in India in January and Zimbabwe cleared it early this month.